Global mRNA Vaccines and mRNA Drugs Market Growth 2026-2032
The global mRNA Vaccines and mRNA Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for mRNA Vaccines and mRNA Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for mRNA Vaccines and mRNA Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for mRNA Vaccines and mRNA Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key mRNA Vaccines and mRNA Drugs players cover Thermo Fisher, Merck, Qiagen N.V., CureVac, In-Cell-Art, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “mRNA Vaccines and mRNA Drugs Industry Forecast” looks at past sales and reviews total world mRNA Vaccines and mRNA Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected mRNA Vaccines and mRNA Drugs sales for 2026 through 2032. With mRNA Vaccines and mRNA Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Vaccines and mRNA Drugs industry.
This Insight Report provides a comprehensive analysis of the global mRNA Vaccines and mRNA Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on mRNA Vaccines and mRNA Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA Vaccines and mRNA Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Vaccines and mRNA Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Vaccines and mRNA Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Vaccines and mRNA Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for mRNA Vaccines and mRNA Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for mRNA Vaccines and mRNA Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for mRNA Vaccines and mRNA Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key mRNA Vaccines and mRNA Drugs players cover Thermo Fisher, Merck, Qiagen N.V., CureVac, In-Cell-Art, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “mRNA Vaccines and mRNA Drugs Industry Forecast” looks at past sales and reviews total world mRNA Vaccines and mRNA Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected mRNA Vaccines and mRNA Drugs sales for 2026 through 2032. With mRNA Vaccines and mRNA Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Vaccines and mRNA Drugs industry.
This Insight Report provides a comprehensive analysis of the global mRNA Vaccines and mRNA Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on mRNA Vaccines and mRNA Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA Vaccines and mRNA Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Vaccines and mRNA Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Vaccines and mRNA Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Vaccines and mRNA Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Vaccine
- API
- Infectious Disease
- Cancer
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Thermo Fisher
- Merck
- Qiagen N.V.
- CureVac
- In-Cell-Art
- eTheRNA
- Takara Bio Inc.
- Sangamo Therapeutics
- Roche CustomBiotech
- BioNTech
- Tiba Biotechnology
- TriLink Bio Technologies
- Argos Therapeutics
- Moderna Therapeutics
- NEB
- Ethris
- Aldevron
- Promega
- Translate Bio
- What is the 10-year outlook for the global mRNA Vaccines and mRNA Drugs market?
- What factors are driving mRNA Vaccines and mRNA Drugs market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do mRNA Vaccines and mRNA Drugs market opportunities vary by end market size?
- How does mRNA Vaccines and mRNA Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA Vaccines and mRNA Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for mRNA Vaccines and mRNA Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for mRNA Vaccines and mRNA Drugs by Country/Region, 2021, 2025 & 2032
2.2 mRNA Vaccines and mRNA Drugs Segment by Type
2.2.1 Vaccine
2.2.2 API
2.2.3 mRNA Vaccines and mRNA Drugs Sales by Type
2.2.3.1 Global mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global mRNA Vaccines and mRNA Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global mRNA Vaccines and mRNA Drugs Sale Price by Type (2021-2026)
2.3 mRNA Vaccines and mRNA Drugs Segment by Application
2.3.1 Infectious Disease
2.3.2 Cancer
2.3.3 mRNA Vaccines and mRNA Drugs Sales by Application
2.3.3.1 Global mRNA Vaccines and mRNA Drugs Sale Market Share by Application (2021-2026)
2.3.3.2 Global mRNA Vaccines and mRNA Drugs Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global mRNA Vaccines and mRNA Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global mRNA Vaccines and mRNA Drugs Breakdown Data by Company
3.1.1 Global mRNA Vaccines and mRNA Drugs Annual Sales by Company (2021-2026)
3.1.2 Global mRNA Vaccines and mRNA Drugs Sales Market Share by Company (2021-2026)
3.2 Global mRNA Vaccines and mRNA Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global mRNA Vaccines and mRNA Drugs Revenue by Company (2021-2026)
3.2.2 Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Company (2021-2026)
3.3 Global mRNA Vaccines and mRNA Drugs Sale Price by Company
3.4 Key Manufacturers mRNA Vaccines and mRNA Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers mRNA Vaccines and mRNA Drugs Product Location Distribution
3.4.2 Players mRNA Vaccines and mRNA Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MRNA VACCINES AND MRNA DRUGS BY GEOGRAPHIC REGION
4.1 World Historic mRNA Vaccines and mRNA Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global mRNA Vaccines and mRNA Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global mRNA Vaccines and mRNA Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic mRNA Vaccines and mRNA Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global mRNA Vaccines and mRNA Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global mRNA Vaccines and mRNA Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas mRNA Vaccines and mRNA Drugs Sales Growth
4.4 APAC mRNA Vaccines and mRNA Drugs Sales Growth
4.5 Europe mRNA Vaccines and mRNA Drugs Sales Growth
4.6 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Growth
5 AMERICAS
5.1 Americas mRNA Vaccines and mRNA Drugs Sales by Country
5.1.1 Americas mRNA Vaccines and mRNA Drugs Sales by Country (2021-2026)
5.1.2 Americas mRNA Vaccines and mRNA Drugs Revenue by Country (2021-2026)
5.2 Americas mRNA Vaccines and mRNA Drugs Sales by Type (2021-2026)
5.3 Americas mRNA Vaccines and mRNA Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Vaccines and mRNA Drugs Sales by Region
6.1.1 APAC mRNA Vaccines and mRNA Drugs Sales by Region (2021-2026)
6.1.2 APAC mRNA Vaccines and mRNA Drugs Revenue by Region (2021-2026)
6.2 APAC mRNA Vaccines and mRNA Drugs Sales by Type (2021-2026)
6.3 APAC mRNA Vaccines and mRNA Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe mRNA Vaccines and mRNA Drugs by Country
7.1.1 Europe mRNA Vaccines and mRNA Drugs Sales by Country (2021-2026)
7.1.2 Europe mRNA Vaccines and mRNA Drugs Revenue by Country (2021-2026)
7.2 Europe mRNA Vaccines and mRNA Drugs Sales by Type (2021-2026)
7.3 Europe mRNA Vaccines and mRNA Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA Vaccines and mRNA Drugs by Country
8.1.1 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of mRNA Vaccines and mRNA Drugs
10.3 Manufacturing Process Analysis of mRNA Vaccines and mRNA Drugs
10.4 Industry Chain Structure of mRNA Vaccines and mRNA Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 mRNA Vaccines and mRNA Drugs Distributors
11.3 mRNA Vaccines and mRNA Drugs Customer
12 WORLD FORECAST REVIEW FOR MRNA VACCINES AND MRNA DRUGS BY GEOGRAPHIC REGION
12.1 Global mRNA Vaccines and mRNA Drugs Market Size Forecast by Region
12.1.1 Global mRNA Vaccines and mRNA Drugs Forecast by Region (2027-2032)
12.1.2 Global mRNA Vaccines and mRNA Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global mRNA Vaccines and mRNA Drugs Forecast by Type (2027-2032)
12.7 Global mRNA Vaccines and mRNA Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Thermo Fisher
13.1.1 Thermo Fisher Company Information
13.1.2 Thermo Fisher mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.1.3 Thermo Fisher mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Thermo Fisher Main Business Overview
13.1.5 Thermo Fisher Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.2.3 Merck mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Qiagen N.V.
13.3.1 Qiagen N.V. Company Information
13.3.2 Qiagen N.V. mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.3.3 Qiagen N.V. mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Qiagen N.V. Main Business Overview
13.3.5 Qiagen N.V. Latest Developments
13.4 CureVac
13.4.1 CureVac Company Information
13.4.2 CureVac mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.4.3 CureVac mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 CureVac Main Business Overview
13.4.5 CureVac Latest Developments
13.5 In-Cell-Art
13.5.1 In-Cell-Art Company Information
13.5.2 In-Cell-Art mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.5.3 In-Cell-Art mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 In-Cell-Art Main Business Overview
13.5.5 In-Cell-Art Latest Developments
13.6 eTheRNA
13.6.1 eTheRNA Company Information
13.6.2 eTheRNA mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.6.3 eTheRNA mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 eTheRNA Main Business Overview
13.6.5 eTheRNA Latest Developments
13.7 Takara Bio Inc.
13.7.1 Takara Bio Inc. Company Information
13.7.2 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.7.3 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Takara Bio Inc. Main Business Overview
13.7.5 Takara Bio Inc. Latest Developments
13.8 Sangamo Therapeutics
13.8.1 Sangamo Therapeutics Company Information
13.8.2 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.8.3 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sangamo Therapeutics Main Business Overview
13.8.5 Sangamo Therapeutics Latest Developments
13.9 Roche CustomBiotech
13.9.1 Roche CustomBiotech Company Information
13.9.2 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.9.3 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Roche CustomBiotech Main Business Overview
13.9.5 Roche CustomBiotech Latest Developments
13.10 BioNTech
13.10.1 BioNTech Company Information
13.10.2 BioNTech mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.10.3 BioNTech mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 BioNTech Main Business Overview
13.10.5 BioNTech Latest Developments
13.11 Tiba Biotechnology
13.11.1 Tiba Biotechnology Company Information
13.11.2 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.11.3 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Tiba Biotechnology Main Business Overview
13.11.5 Tiba Biotechnology Latest Developments
13.12 TriLink Bio Technologies
13.12.1 TriLink Bio Technologies Company Information
13.12.2 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.12.3 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 TriLink Bio Technologies Main Business Overview
13.12.5 TriLink Bio Technologies Latest Developments
13.13 Argos Therapeutics
13.13.1 Argos Therapeutics Company Information
13.13.2 Argos Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.13.3 Argos Therapeutics mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Argos Therapeutics Main Business Overview
13.13.5 Argos Therapeutics Latest Developments
13.14 Moderna Therapeutics
13.14.1 Moderna Therapeutics Company Information
13.14.2 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.14.3 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Moderna Therapeutics Main Business Overview
13.14.5 Moderna Therapeutics Latest Developments
13.15 NEB
13.15.1 NEB Company Information
13.15.2 NEB mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.15.3 NEB mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 NEB Main Business Overview
13.15.5 NEB Latest Developments
13.16 Ethris
13.16.1 Ethris Company Information
13.16.2 Ethris mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.16.3 Ethris mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Ethris Main Business Overview
13.16.5 Ethris Latest Developments
13.17 Aldevron
13.17.1 Aldevron Company Information
13.17.2 Aldevron mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.17.3 Aldevron mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Aldevron Main Business Overview
13.17.5 Aldevron Latest Developments
13.18 Promega
13.18.1 Promega Company Information
13.18.2 Promega mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.18.3 Promega mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Promega Main Business Overview
13.18.5 Promega Latest Developments
13.19 Translate Bio
13.19.1 Translate Bio Company Information
13.19.2 Translate Bio mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.19.3 Translate Bio mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Translate Bio Main Business Overview
13.19.5 Translate Bio Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA Vaccines and mRNA Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for mRNA Vaccines and mRNA Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for mRNA Vaccines and mRNA Drugs by Country/Region, 2021, 2025 & 2032
2.2 mRNA Vaccines and mRNA Drugs Segment by Type
2.2.1 Vaccine
2.2.2 API
2.2.3 mRNA Vaccines and mRNA Drugs Sales by Type
2.2.3.1 Global mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global mRNA Vaccines and mRNA Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global mRNA Vaccines and mRNA Drugs Sale Price by Type (2021-2026)
2.3 mRNA Vaccines and mRNA Drugs Segment by Application
2.3.1 Infectious Disease
2.3.2 Cancer
2.3.3 mRNA Vaccines and mRNA Drugs Sales by Application
2.3.3.1 Global mRNA Vaccines and mRNA Drugs Sale Market Share by Application (2021-2026)
2.3.3.2 Global mRNA Vaccines and mRNA Drugs Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global mRNA Vaccines and mRNA Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global mRNA Vaccines and mRNA Drugs Breakdown Data by Company
3.1.1 Global mRNA Vaccines and mRNA Drugs Annual Sales by Company (2021-2026)
3.1.2 Global mRNA Vaccines and mRNA Drugs Sales Market Share by Company (2021-2026)
3.2 Global mRNA Vaccines and mRNA Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global mRNA Vaccines and mRNA Drugs Revenue by Company (2021-2026)
3.2.2 Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Company (2021-2026)
3.3 Global mRNA Vaccines and mRNA Drugs Sale Price by Company
3.4 Key Manufacturers mRNA Vaccines and mRNA Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers mRNA Vaccines and mRNA Drugs Product Location Distribution
3.4.2 Players mRNA Vaccines and mRNA Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MRNA VACCINES AND MRNA DRUGS BY GEOGRAPHIC REGION
4.1 World Historic mRNA Vaccines and mRNA Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global mRNA Vaccines and mRNA Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global mRNA Vaccines and mRNA Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic mRNA Vaccines and mRNA Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global mRNA Vaccines and mRNA Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global mRNA Vaccines and mRNA Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas mRNA Vaccines and mRNA Drugs Sales Growth
4.4 APAC mRNA Vaccines and mRNA Drugs Sales Growth
4.5 Europe mRNA Vaccines and mRNA Drugs Sales Growth
4.6 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Growth
5 AMERICAS
5.1 Americas mRNA Vaccines and mRNA Drugs Sales by Country
5.1.1 Americas mRNA Vaccines and mRNA Drugs Sales by Country (2021-2026)
5.1.2 Americas mRNA Vaccines and mRNA Drugs Revenue by Country (2021-2026)
5.2 Americas mRNA Vaccines and mRNA Drugs Sales by Type (2021-2026)
5.3 Americas mRNA Vaccines and mRNA Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Vaccines and mRNA Drugs Sales by Region
6.1.1 APAC mRNA Vaccines and mRNA Drugs Sales by Region (2021-2026)
6.1.2 APAC mRNA Vaccines and mRNA Drugs Revenue by Region (2021-2026)
6.2 APAC mRNA Vaccines and mRNA Drugs Sales by Type (2021-2026)
6.3 APAC mRNA Vaccines and mRNA Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe mRNA Vaccines and mRNA Drugs by Country
7.1.1 Europe mRNA Vaccines and mRNA Drugs Sales by Country (2021-2026)
7.1.2 Europe mRNA Vaccines and mRNA Drugs Revenue by Country (2021-2026)
7.2 Europe mRNA Vaccines and mRNA Drugs Sales by Type (2021-2026)
7.3 Europe mRNA Vaccines and mRNA Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA Vaccines and mRNA Drugs by Country
8.1.1 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of mRNA Vaccines and mRNA Drugs
10.3 Manufacturing Process Analysis of mRNA Vaccines and mRNA Drugs
10.4 Industry Chain Structure of mRNA Vaccines and mRNA Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 mRNA Vaccines and mRNA Drugs Distributors
11.3 mRNA Vaccines and mRNA Drugs Customer
12 WORLD FORECAST REVIEW FOR MRNA VACCINES AND MRNA DRUGS BY GEOGRAPHIC REGION
12.1 Global mRNA Vaccines and mRNA Drugs Market Size Forecast by Region
12.1.1 Global mRNA Vaccines and mRNA Drugs Forecast by Region (2027-2032)
12.1.2 Global mRNA Vaccines and mRNA Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global mRNA Vaccines and mRNA Drugs Forecast by Type (2027-2032)
12.7 Global mRNA Vaccines and mRNA Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Thermo Fisher
13.1.1 Thermo Fisher Company Information
13.1.2 Thermo Fisher mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.1.3 Thermo Fisher mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Thermo Fisher Main Business Overview
13.1.5 Thermo Fisher Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.2.3 Merck mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Qiagen N.V.
13.3.1 Qiagen N.V. Company Information
13.3.2 Qiagen N.V. mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.3.3 Qiagen N.V. mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Qiagen N.V. Main Business Overview
13.3.5 Qiagen N.V. Latest Developments
13.4 CureVac
13.4.1 CureVac Company Information
13.4.2 CureVac mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.4.3 CureVac mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 CureVac Main Business Overview
13.4.5 CureVac Latest Developments
13.5 In-Cell-Art
13.5.1 In-Cell-Art Company Information
13.5.2 In-Cell-Art mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.5.3 In-Cell-Art mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 In-Cell-Art Main Business Overview
13.5.5 In-Cell-Art Latest Developments
13.6 eTheRNA
13.6.1 eTheRNA Company Information
13.6.2 eTheRNA mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.6.3 eTheRNA mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 eTheRNA Main Business Overview
13.6.5 eTheRNA Latest Developments
13.7 Takara Bio Inc.
13.7.1 Takara Bio Inc. Company Information
13.7.2 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.7.3 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Takara Bio Inc. Main Business Overview
13.7.5 Takara Bio Inc. Latest Developments
13.8 Sangamo Therapeutics
13.8.1 Sangamo Therapeutics Company Information
13.8.2 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.8.3 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sangamo Therapeutics Main Business Overview
13.8.5 Sangamo Therapeutics Latest Developments
13.9 Roche CustomBiotech
13.9.1 Roche CustomBiotech Company Information
13.9.2 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.9.3 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Roche CustomBiotech Main Business Overview
13.9.5 Roche CustomBiotech Latest Developments
13.10 BioNTech
13.10.1 BioNTech Company Information
13.10.2 BioNTech mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.10.3 BioNTech mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 BioNTech Main Business Overview
13.10.5 BioNTech Latest Developments
13.11 Tiba Biotechnology
13.11.1 Tiba Biotechnology Company Information
13.11.2 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.11.3 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Tiba Biotechnology Main Business Overview
13.11.5 Tiba Biotechnology Latest Developments
13.12 TriLink Bio Technologies
13.12.1 TriLink Bio Technologies Company Information
13.12.2 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.12.3 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 TriLink Bio Technologies Main Business Overview
13.12.5 TriLink Bio Technologies Latest Developments
13.13 Argos Therapeutics
13.13.1 Argos Therapeutics Company Information
13.13.2 Argos Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.13.3 Argos Therapeutics mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Argos Therapeutics Main Business Overview
13.13.5 Argos Therapeutics Latest Developments
13.14 Moderna Therapeutics
13.14.1 Moderna Therapeutics Company Information
13.14.2 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.14.3 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Moderna Therapeutics Main Business Overview
13.14.5 Moderna Therapeutics Latest Developments
13.15 NEB
13.15.1 NEB Company Information
13.15.2 NEB mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.15.3 NEB mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 NEB Main Business Overview
13.15.5 NEB Latest Developments
13.16 Ethris
13.16.1 Ethris Company Information
13.16.2 Ethris mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.16.3 Ethris mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Ethris Main Business Overview
13.16.5 Ethris Latest Developments
13.17 Aldevron
13.17.1 Aldevron Company Information
13.17.2 Aldevron mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.17.3 Aldevron mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Aldevron Main Business Overview
13.17.5 Aldevron Latest Developments
13.18 Promega
13.18.1 Promega Company Information
13.18.2 Promega mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.18.3 Promega mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Promega Main Business Overview
13.18.5 Promega Latest Developments
13.19 Translate Bio
13.19.1 Translate Bio Company Information
13.19.2 Translate Bio mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.19.3 Translate Bio mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Translate Bio Main Business Overview
13.19.5 Translate Bio Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. mRNA Vaccines and mRNA Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. mRNA Vaccines and mRNA Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Vaccine
Table 4. Major Players of API
Table 5. Global mRNA Vaccines and mRNA Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2021-2026)
Table 7. Global mRNA Vaccines and mRNA Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global mRNA Vaccines and mRNA Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global mRNA Vaccines and mRNA Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global mRNA Vaccines and mRNA Drugs Sale Market Share by Application (2021-2026)
Table 12. Global mRNA Vaccines and mRNA Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global mRNA Vaccines and mRNA Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global mRNA Vaccines and mRNA Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Company (2021-2026)
Table 17. Global mRNA Vaccines and mRNA Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global mRNA Vaccines and mRNA Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers mRNA Vaccines and mRNA Drugs Producing Area Distribution and Sales Area
Table 21. Players mRNA Vaccines and mRNA Drugs Products Offered
Table 22. mRNA Vaccines and mRNA Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global mRNA Vaccines and mRNA Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global mRNA Vaccines and mRNA Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global mRNA Vaccines and mRNA Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global mRNA Vaccines and mRNA Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global mRNA Vaccines and mRNA Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas mRNA Vaccines and mRNA Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas mRNA Vaccines and mRNA Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas mRNA Vaccines and mRNA Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas mRNA Vaccines and mRNA Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas mRNA Vaccines and mRNA Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC mRNA Vaccines and mRNA Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC mRNA Vaccines and mRNA Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC mRNA Vaccines and mRNA Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC mRNA Vaccines and mRNA Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC mRNA Vaccines and mRNA Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe mRNA Vaccines and mRNA Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe mRNA Vaccines and mRNA Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe mRNA Vaccines and mRNA Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe mRNA Vaccines and mRNA Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of mRNA Vaccines and mRNA Drugs
Table 52. Key Market Challenges & Risks of mRNA Vaccines and mRNA Drugs
Table 53. Key Industry Trends of mRNA Vaccines and mRNA Drugs
Table 54. mRNA Vaccines and mRNA Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. mRNA Vaccines and mRNA Drugs Distributors List
Table 57. mRNA Vaccines and mRNA Drugs Customer List
Table 58. Global mRNA Vaccines and mRNA Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global mRNA Vaccines and mRNA Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas mRNA Vaccines and mRNA Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas mRNA Vaccines and mRNA Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC mRNA Vaccines and mRNA Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC mRNA Vaccines and mRNA Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe mRNA Vaccines and mRNA Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe mRNA Vaccines and mRNA Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global mRNA Vaccines and mRNA Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global mRNA Vaccines and mRNA Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global mRNA Vaccines and mRNA Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global mRNA Vaccines and mRNA Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Thermo Fisher Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Thermo Fisher mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 74. Thermo Fisher mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Thermo Fisher Main Business
Table 76. Thermo Fisher Latest Developments
Table 77. Merck Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Merck mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 79. Merck mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Merck Main Business
Table 81. Merck Latest Developments
Table 82. Qiagen N.V. Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Qiagen N.V. mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 84. Qiagen N.V. mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Qiagen N.V. Main Business
Table 86. Qiagen N.V. Latest Developments
Table 87. CureVac Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. CureVac mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 89. CureVac mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. CureVac Main Business
Table 91. CureVac Latest Developments
Table 92. In-Cell-Art Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. In-Cell-Art mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 94. In-Cell-Art mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. In-Cell-Art Main Business
Table 96. In-Cell-Art Latest Developments
Table 97. eTheRNA Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. eTheRNA mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 99. eTheRNA mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. eTheRNA Main Business
Table 101. eTheRNA Latest Developments
Table 102. Takara Bio Inc. Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 104. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Takara Bio Inc. Main Business
Table 106. Takara Bio Inc. Latest Developments
Table 107. Sangamo Therapeutics Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 109. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Sangamo Therapeutics Main Business
Table 111. Sangamo Therapeutics Latest Developments
Table 112. Roche CustomBiotech Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 114. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Roche CustomBiotech Main Business
Table 116. Roche CustomBiotech Latest Developments
Table 117. BioNTech Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. BioNTech mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 119. BioNTech mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. BioNTech Main Business
Table 121. BioNTech Latest Developments
Table 122. Tiba Biotechnology Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 124. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Tiba Biotechnology Main Business
Table 126. Tiba Biotechnology Latest Developments
Table 127. TriLink Bio Technologies Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 129. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. TriLink Bio Technologies Main Business
Table 131. TriLink Bio Technologies Latest Developments
Table 132. Argos Therapeutics Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Argos Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 134. Argos Therapeutics mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Argos Therapeutics Main Business
Table 136. Argos Therapeutics Latest Developments
Table 137. Moderna Therapeutics Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 139. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Moderna Therapeutics Main Business
Table 141. Moderna Therapeutics Latest Developments
Table 142. NEB Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. NEB mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 144. NEB mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. NEB Main Business
Table 146. NEB Latest Developments
Table 147. Ethris Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. Ethris mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 149. Ethris mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Ethris Main Business
Table 151. Ethris Latest Developments
Table 152. Aldevron Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Aldevron mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 154. Aldevron mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Aldevron Main Business
Table 156. Aldevron Latest Developments
Table 157. Promega Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. Promega mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 159. Promega mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Promega Main Business
Table 161. Promega Latest Developments
Table 162. Translate Bio Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 163. Translate Bio mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 164. Translate Bio mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Translate Bio Main Business
Table 166. Translate Bio Latest Developments
Table 1. mRNA Vaccines and mRNA Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. mRNA Vaccines and mRNA Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Vaccine
Table 4. Major Players of API
Table 5. Global mRNA Vaccines and mRNA Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2021-2026)
Table 7. Global mRNA Vaccines and mRNA Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global mRNA Vaccines and mRNA Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global mRNA Vaccines and mRNA Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global mRNA Vaccines and mRNA Drugs Sale Market Share by Application (2021-2026)
Table 12. Global mRNA Vaccines and mRNA Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global mRNA Vaccines and mRNA Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global mRNA Vaccines and mRNA Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Company (2021-2026)
Table 17. Global mRNA Vaccines and mRNA Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global mRNA Vaccines and mRNA Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers mRNA Vaccines and mRNA Drugs Producing Area Distribution and Sales Area
Table 21. Players mRNA Vaccines and mRNA Drugs Products Offered
Table 22. mRNA Vaccines and mRNA Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global mRNA Vaccines and mRNA Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global mRNA Vaccines and mRNA Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global mRNA Vaccines and mRNA Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global mRNA Vaccines and mRNA Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global mRNA Vaccines and mRNA Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas mRNA Vaccines and mRNA Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas mRNA Vaccines and mRNA Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas mRNA Vaccines and mRNA Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas mRNA Vaccines and mRNA Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas mRNA Vaccines and mRNA Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC mRNA Vaccines and mRNA Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC mRNA Vaccines and mRNA Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC mRNA Vaccines and mRNA Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC mRNA Vaccines and mRNA Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC mRNA Vaccines and mRNA Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe mRNA Vaccines and mRNA Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe mRNA Vaccines and mRNA Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe mRNA Vaccines and mRNA Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe mRNA Vaccines and mRNA Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of mRNA Vaccines and mRNA Drugs
Table 52. Key Market Challenges & Risks of mRNA Vaccines and mRNA Drugs
Table 53. Key Industry Trends of mRNA Vaccines and mRNA Drugs
Table 54. mRNA Vaccines and mRNA Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. mRNA Vaccines and mRNA Drugs Distributors List
Table 57. mRNA Vaccines and mRNA Drugs Customer List
Table 58. Global mRNA Vaccines and mRNA Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global mRNA Vaccines and mRNA Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas mRNA Vaccines and mRNA Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas mRNA Vaccines and mRNA Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC mRNA Vaccines and mRNA Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC mRNA Vaccines and mRNA Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe mRNA Vaccines and mRNA Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe mRNA Vaccines and mRNA Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global mRNA Vaccines and mRNA Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global mRNA Vaccines and mRNA Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global mRNA Vaccines and mRNA Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global mRNA Vaccines and mRNA Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Thermo Fisher Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Thermo Fisher mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 74. Thermo Fisher mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Thermo Fisher Main Business
Table 76. Thermo Fisher Latest Developments
Table 77. Merck Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Merck mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 79. Merck mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Merck Main Business
Table 81. Merck Latest Developments
Table 82. Qiagen N.V. Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Qiagen N.V. mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 84. Qiagen N.V. mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Qiagen N.V. Main Business
Table 86. Qiagen N.V. Latest Developments
Table 87. CureVac Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. CureVac mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 89. CureVac mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. CureVac Main Business
Table 91. CureVac Latest Developments
Table 92. In-Cell-Art Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. In-Cell-Art mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 94. In-Cell-Art mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. In-Cell-Art Main Business
Table 96. In-Cell-Art Latest Developments
Table 97. eTheRNA Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. eTheRNA mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 99. eTheRNA mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. eTheRNA Main Business
Table 101. eTheRNA Latest Developments
Table 102. Takara Bio Inc. Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 104. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Takara Bio Inc. Main Business
Table 106. Takara Bio Inc. Latest Developments
Table 107. Sangamo Therapeutics Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 109. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Sangamo Therapeutics Main Business
Table 111. Sangamo Therapeutics Latest Developments
Table 112. Roche CustomBiotech Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 114. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Roche CustomBiotech Main Business
Table 116. Roche CustomBiotech Latest Developments
Table 117. BioNTech Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. BioNTech mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 119. BioNTech mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. BioNTech Main Business
Table 121. BioNTech Latest Developments
Table 122. Tiba Biotechnology Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 124. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Tiba Biotechnology Main Business
Table 126. Tiba Biotechnology Latest Developments
Table 127. TriLink Bio Technologies Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 129. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. TriLink Bio Technologies Main Business
Table 131. TriLink Bio Technologies Latest Developments
Table 132. Argos Therapeutics Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Argos Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 134. Argos Therapeutics mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Argos Therapeutics Main Business
Table 136. Argos Therapeutics Latest Developments
Table 137. Moderna Therapeutics Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 139. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Moderna Therapeutics Main Business
Table 141. Moderna Therapeutics Latest Developments
Table 142. NEB Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. NEB mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 144. NEB mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. NEB Main Business
Table 146. NEB Latest Developments
Table 147. Ethris Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. Ethris mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 149. Ethris mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Ethris Main Business
Table 151. Ethris Latest Developments
Table 152. Aldevron Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Aldevron mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 154. Aldevron mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Aldevron Main Business
Table 156. Aldevron Latest Developments
Table 157. Promega Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. Promega mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 159. Promega mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Promega Main Business
Table 161. Promega Latest Developments
Table 162. Translate Bio Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 163. Translate Bio mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 164. Translate Bio mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Translate Bio Main Business
Table 166. Translate Bio Latest Developments
LIST OF FIGURES
Figure 1. Picture of mRNA Vaccines and mRNA Drugs
Figure 2. mRNA Vaccines and mRNA Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global mRNA Vaccines and mRNA Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global mRNA Vaccines and mRNA Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. mRNA Vaccines and mRNA Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. mRNA Vaccines and mRNA Drugs Sales Market Share by Country/Region (2025)
Figure 10. mRNA Vaccines and mRNA Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Vaccine
Figure 12. Product Picture of API
Figure 13. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Type in 2026
Figure 14. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Type (2021-2026)
Figure 15. mRNA Vaccines and mRNA Drugs Consumed in Infectious Disease
Figure 16. Global mRNA Vaccines and mRNA Drugs Market: Infectious Disease (2021-2026) & (K Units)
Figure 17. mRNA Vaccines and mRNA Drugs Consumed in Cancer
Figure 18. Global mRNA Vaccines and mRNA Drugs Market: Cancer (2021-2026) & (K Units)
Figure 19. Global mRNA Vaccines and mRNA Drugs Sale Market Share by Application (2025)
Figure 20. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Application in 2026
Figure 21. mRNA Vaccines and mRNA Drugs Sales by Company in 2026 (K Units)
Figure 22. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Company in 2026
Figure 23. mRNA Vaccines and mRNA Drugs Revenue by Company in 2026 ($ millions)
Figure 24. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Company in 2026
Figure 25. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Geographic Region in 2026
Figure 27. Americas mRNA Vaccines and mRNA Drugs Sales 2021-2026 (K Units)
Figure 28. Americas mRNA Vaccines and mRNA Drugs Revenue 2021-2026 ($ millions)
Figure 29. APAC mRNA Vaccines and mRNA Drugs Sales 2021-2026 (K Units)
Figure 30. APAC mRNA Vaccines and mRNA Drugs Revenue 2021-2026 ($ millions)
Figure 31. Europe mRNA Vaccines and mRNA Drugs Sales 2021-2026 (K Units)
Figure 32. Europe mRNA Vaccines and mRNA Drugs Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue 2021-2026 ($ millions)
Figure 35. Americas mRNA Vaccines and mRNA Drugs Sales Market Share by Country in 2026
Figure 36. Americas mRNA Vaccines and mRNA Drugs Revenue Market Share by Country (2021-2026)
Figure 37. Americas mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2021-2026)
Figure 38. Americas mRNA Vaccines and mRNA Drugs Sales Market Share by Application (2021-2026)
Figure 39. United States mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC mRNA Vaccines and mRNA Drugs Sales Market Share by Region in 2026
Figure 44. APAC mRNA Vaccines and mRNA Drugs Revenue Market Share by Region (2021-2026)
Figure 45. APAC mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2021-2026)
Figure 46. APAC mRNA Vaccines and mRNA Drugs Sales Market Share by Application (2021-2026)
Figure 47. China mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. India mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe mRNA Vaccines and mRNA Drugs Sales Market Share by Country in 2026
Figure 55. Europe mRNA Vaccines and mRNA Drugs Revenue Market Share by Country (2021-2026)
Figure 56. Europe mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2021-2026)
Figure 57. Europe mRNA Vaccines and mRNA Drugs Sales Market Share by Application (2021-2026)
Figure 58. Germany mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 59. France mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 60. UK mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Market Share by Application (2021-2026)
Figure 66. Egypt mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of mRNA Vaccines and mRNA Drugs in 2026
Figure 72. Manufacturing Process Analysis of mRNA Vaccines and mRNA Drugs
Figure 73. Industry Chain Structure of mRNA Vaccines and mRNA Drugs
Figure 74. Channels of Distribution
Figure 75. Global mRNA Vaccines and mRNA Drugs Sales Market Forecast by Region (2027-2032)
Figure 76. Global mRNA Vaccines and mRNA Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global mRNA Vaccines and mRNA Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global mRNA Vaccines and mRNA Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global mRNA Vaccines and mRNA Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global mRNA Vaccines and mRNA Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of mRNA Vaccines and mRNA Drugs
Figure 2. mRNA Vaccines and mRNA Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global mRNA Vaccines and mRNA Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global mRNA Vaccines and mRNA Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. mRNA Vaccines and mRNA Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. mRNA Vaccines and mRNA Drugs Sales Market Share by Country/Region (2025)
Figure 10. mRNA Vaccines and mRNA Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Vaccine
Figure 12. Product Picture of API
Figure 13. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Type in 2026
Figure 14. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Type (2021-2026)
Figure 15. mRNA Vaccines and mRNA Drugs Consumed in Infectious Disease
Figure 16. Global mRNA Vaccines and mRNA Drugs Market: Infectious Disease (2021-2026) & (K Units)
Figure 17. mRNA Vaccines and mRNA Drugs Consumed in Cancer
Figure 18. Global mRNA Vaccines and mRNA Drugs Market: Cancer (2021-2026) & (K Units)
Figure 19. Global mRNA Vaccines and mRNA Drugs Sale Market Share by Application (2025)
Figure 20. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Application in 2026
Figure 21. mRNA Vaccines and mRNA Drugs Sales by Company in 2026 (K Units)
Figure 22. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Company in 2026
Figure 23. mRNA Vaccines and mRNA Drugs Revenue by Company in 2026 ($ millions)
Figure 24. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Company in 2026
Figure 25. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Geographic Region in 2026
Figure 27. Americas mRNA Vaccines and mRNA Drugs Sales 2021-2026 (K Units)
Figure 28. Americas mRNA Vaccines and mRNA Drugs Revenue 2021-2026 ($ millions)
Figure 29. APAC mRNA Vaccines and mRNA Drugs Sales 2021-2026 (K Units)
Figure 30. APAC mRNA Vaccines and mRNA Drugs Revenue 2021-2026 ($ millions)
Figure 31. Europe mRNA Vaccines and mRNA Drugs Sales 2021-2026 (K Units)
Figure 32. Europe mRNA Vaccines and mRNA Drugs Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue 2021-2026 ($ millions)
Figure 35. Americas mRNA Vaccines and mRNA Drugs Sales Market Share by Country in 2026
Figure 36. Americas mRNA Vaccines and mRNA Drugs Revenue Market Share by Country (2021-2026)
Figure 37. Americas mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2021-2026)
Figure 38. Americas mRNA Vaccines and mRNA Drugs Sales Market Share by Application (2021-2026)
Figure 39. United States mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC mRNA Vaccines and mRNA Drugs Sales Market Share by Region in 2026
Figure 44. APAC mRNA Vaccines and mRNA Drugs Revenue Market Share by Region (2021-2026)
Figure 45. APAC mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2021-2026)
Figure 46. APAC mRNA Vaccines and mRNA Drugs Sales Market Share by Application (2021-2026)
Figure 47. China mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. India mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe mRNA Vaccines and mRNA Drugs Sales Market Share by Country in 2026
Figure 55. Europe mRNA Vaccines and mRNA Drugs Revenue Market Share by Country (2021-2026)
Figure 56. Europe mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2021-2026)
Figure 57. Europe mRNA Vaccines and mRNA Drugs Sales Market Share by Application (2021-2026)
Figure 58. Germany mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 59. France mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 60. UK mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Market Share by Application (2021-2026)
Figure 66. Egypt mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries mRNA Vaccines and mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of mRNA Vaccines and mRNA Drugs in 2026
Figure 72. Manufacturing Process Analysis of mRNA Vaccines and mRNA Drugs
Figure 73. Industry Chain Structure of mRNA Vaccines and mRNA Drugs
Figure 74. Channels of Distribution
Figure 75. Global mRNA Vaccines and mRNA Drugs Sales Market Forecast by Region (2027-2032)
Figure 76. Global mRNA Vaccines and mRNA Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global mRNA Vaccines and mRNA Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global mRNA Vaccines and mRNA Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global mRNA Vaccines and mRNA Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global mRNA Vaccines and mRNA Drugs Revenue Market Share Forecast by Application (2027-2032)
